These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Elevated DNA methylation in malignant tumors of the sinonasal tract and its association with patient survival. Chmelarova M; Laco J; Kovarikova H; Baranova I; Dundr P; Nemejcova K; Michalek J; Vosmik M; Palicka V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):232-238. PubMed ID: 29581595 [TBL] [Abstract][Full Text] [Related]
64. The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy. Akman T; Oztop I; Baskin Y; Akbarpour M; Unal OU; Oflazoglu U; Ellidokuz H; Lebe B Med Oncol; 2015 Jan; 32(1):440. PubMed ID: 25502087 [TBL] [Abstract][Full Text] [Related]
65. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472 [TBL] [Abstract][Full Text] [Related]
66. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504 [TBL] [Abstract][Full Text] [Related]
67. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients. Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523 [TBL] [Abstract][Full Text] [Related]
68. Association of aberrant DNA methylation with clinicopathological features in breast cancer. Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596 [TBL] [Abstract][Full Text] [Related]
69. Clinical and prognostic effects of Xia L; Zhang W; Gao L Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782 [No Abstract] [Full Text] [Related]
70. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A; J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783 [TBL] [Abstract][Full Text] [Related]
71. Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Straume O; Smeds J; Kumar R; Hemminki K; Akslen LA Am J Pathol; 2002 Jul; 161(1):229-37. PubMed ID: 12107107 [TBL] [Abstract][Full Text] [Related]
72. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers? Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418 [TBL] [Abstract][Full Text] [Related]
73. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
74. Promoter methylation profiling of 30 genes in human malignant melanoma. Furuta J; Umebayashi Y; Miyamoto K; Kikuchi K; Otsuka F; Sugimura T; Ushijima T Cancer Sci; 2004 Dec; 95(12):962-8. PubMed ID: 15596045 [TBL] [Abstract][Full Text] [Related]
75. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status. Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438 [TBL] [Abstract][Full Text] [Related]
77. BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival. Hugdahl E; Kalvenes MB; Puntervoll HE; Ladstein RG; Akslen LA Br J Cancer; 2016 Mar; 114(7):801-8. PubMed ID: 26924424 [TBL] [Abstract][Full Text] [Related]
78. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma. Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ Elife; 2019 Jun; 8():. PubMed ID: 31169496 [TBL] [Abstract][Full Text] [Related]